Unknown

Dataset Information

0

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.


ABSTRACT:

Purpose

Favourable small cell lung carcinoma (SCLC) survival outcomes have been reported in patients with paraneoplastic neurological disorders (PNDs) associated with neuronal antibodies (Neur-Abs), but the presence of a PND might have expedited diagnosis. Our aim was to establish whether neuronal antibodies, independent of clinical neurological features, correlate with SCLC survival.

Experimental design

262 consecutive SCLC patients were examined: of these, 24 with neurological disease were excluded from this study. The remaining 238 were tested for a broad array of Neur-Abs at the time of cancer diagnosis; survival time was established from follow-up clinical data.

Results

Median survival of the non-PND cohort (n = 238) was 9.5 months. 103 patients (43%) had one or more antigen-defined Neur-Abs. We found significantly longer median survival in 23 patients (10%) with HuD/anti-neuronal nuclear antibody type 1 (ANNA-1, 13.0 months P = 0.037), but not with any of the other antigen-defined antibodies, including the PND-related SOX2 (n = 56, 24%). An additional 28 patients (12%) had uncharacterised anti-neuronal nuclear antibodies (ANNA-U); their median survival time was longer still (15.0 months, P = 0.0048), contrasting with the survival time in patients with non-neuronal anti-nuclear antibodies (detected using HEp-2 cells, n = 23 (10%), 9.25 months). In multivariate analyses, both ANNA-1 and ANNA-U independently reduced the mortality hazard by a ratio of 0.532 (P = 0.01) and 0.430 (P<0.001) respectively.

Conclusions

ANNAs, including the newly described ANNA-U, may be key components of the SCLC immunome and have a potential role in predicting SCLC survival; screening for them could add prognostic value that is similar in magnitude to that of limited staging at diagnosis.

SUBMITTER: Gozzard P 

PROVIDER: S-EPMC4659625 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.

Gozzard Paul P   Chapman Caroline C   Vincent Angela A   Lang Bethan B   Maddison Paul P  

PloS one 20151125 11


<h4>Purpose</h4>Favourable small cell lung carcinoma (SCLC) survival outcomes have been reported in patients with paraneoplastic neurological disorders (PNDs) associated with neuronal antibodies (Neur-Abs), but the presence of a PND might have expedited diagnosis. Our aim was to establish whether neuronal antibodies, independent of clinical neurological features, correlate with SCLC survival.<h4>Experimental design</h4>262 consecutive SCLC patients were examined: of these, 24 with neurological d  ...[more]

Similar Datasets

| S-EPMC4516293 | biostudies-literature
| S-EPMC3594265 | biostudies-literature
| S-EPMC7118334 | biostudies-literature
| S-EPMC7962524 | biostudies-literature
| S-EPMC3728564 | biostudies-literature
| S-EPMC4348413 | biostudies-literature
| S-EPMC8428342 | biostudies-literature
| S-ECPF-GEOD-33363 | biostudies-other
| S-EPMC2042516 | biostudies-literature
| S-EPMC7795388 | biostudies-literature